Report DMCA Very-low-dose decitabine treatment for patients with intermediate- or high-risk myelodysplastic syndrome: a retrospectiv
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.